CSI Market
Sign In | Register

Advanced Biomedical Technologies Inc (ABMT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ABMT quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Advanced Biomedical Technologies Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Oct 31 2020)
12 Months 		(Oct 31 2019) (Oct 31 2018) (Oct 31 2017) (Oct 31 2016)
Operating Activities
Income-0.67
Depreciation & amortization0.02
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.03
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.05
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Income Loss Attributable To Noncontrolling Interest-
Imputed Interest-
Increase Decrease In Government Grants Receivable-
Increase Decrease In Other Receivables And Prepaid Expenses-
Depreciation Cashflow-
Depreciation On Rightofuse Assets0.04
Interest On Lease Liabilities0.00
Depreciation On Operating Lease Rightofuse Assets0.01
Interest Expense Debt-
Depreciation On Operating Leases Rightofuse Assets-
Interest Expense-
Interest On Operating Leases Liabilities-
Increase Decrease In Depreciation Allocated To Inventory-
Net Exchange Difference-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities1.19
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.01
Discontinued operations0.00
Net Cash flow from Operating Activities0.65
Investing Activities
Capital Expenditures-0.03
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Construction In Progress Expenditures Incurred But Not Yet Paid-
Proceeds From Construction In Progress-
Payments For Renovation Of Factory Premises-
Renovation Of Factory Premises-
Deposit For Purchase Of Plant And Equipment-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.03
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.45
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.01
Distributed Earnings-
Due To Officers Or Stockholders Current-
Due To Officers Or Stockholders-
Due To Related Parties Current-
Proceeds From Due To Related Parties-
Repayments To Officer Or Stockholders-
Proceeds From Stockholder0.05
Payments Of Proceeds From Capital Element Of Lease Rental Paid-0.04
Payments Of Proceeds From Interest Element Of Lease Rental Paid0.00
Payments Of Proceeds From Principal Element Of Operating Lease Payments-
Payments Of Proceeds From Interest Element Of Operating Lease Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.43
Effect of exchange rate on cash flow0.01
Discontinued operations0.00
Free Cash Flow0.62
Total Cash Flow0.20
4 historic quarters locked

Sign in to unlock the full Advanced Biomedical Technologies Inc cash flow history.

Sign In Create Free Account

About ABMT Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License